| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/25/2002 | WO2002033073A1 Degraded agonist antibody |
| 04/25/2002 | WO2002033072A1 Degraded tpo agonist antibody |
| 04/25/2002 | WO2002033049A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | WO2002033043A2 Method and marker for the isolation of human multipotent hematopoietic stem cells |
| 04/25/2002 | WO2002033042A2 Recombinant antibody fragments as autoantibody antagonists |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032955A1 Human gene critical to fertility |
| 04/25/2002 | WO2002032954A2 Phosphorylation modifications of apoptin |
| 04/25/2002 | WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | WO2002032946A2 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae |
| 04/25/2002 | WO2002032945A2 Haemophilus influenzae basb206 gene and protein |
| 04/25/2002 | WO2002032944A2 Basb208 nucleotide and amino acid sequences from haemophilus influenzae |
| 04/25/2002 | WO2002032940A2 Osteopontin-coated surfaces and methods of use |
| 04/25/2002 | WO2002032937A2 Neuromedin u delta |
| 04/25/2002 | WO2002032936A2 E. histolytica-specific antibodies and clinical uses thereof |
| 04/25/2002 | WO2002032935A1 Immunoenzymatic quantification method |
| 04/25/2002 | WO2002032925A2 Protein scaffolds for antibody mimics and other binding proteins |
| 04/25/2002 | WO2002032456A1 Remedies or preventives for rheumatoid arthritis |
| 04/25/2002 | WO2002032452A1 Composition for aids and method producing it |
| 04/25/2002 | WO2002032445A2 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
| 04/25/2002 | WO2002032375A2 Uses of monoclonal antibody 8h9 |
| 04/25/2002 | WO2002032288A2 Cd38 modulated chemotaxis |
| 04/25/2002 | WO2002032286A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2001092340A3 Use of interleukin-4 antagonists and compositions thereof |
| 04/25/2002 | WO2001088136A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2001078698A3 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain |
| 04/25/2002 | WO2001068880A3 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 04/25/2002 | WO2001062908A3 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 04/25/2002 | WO2001062300A3 Caspase activated prodrugs therapy |
| 04/25/2002 | WO2001048214A3 METHOD FOR PRODUCING 6-0-α-D-GLUCOPYRANOSYL-D-SORBITE |
| 04/25/2002 | WO2001047533A3 INHIBITION OF GSK-3$g(b) |
| 04/25/2002 | WO2001042471A3 Polypeptides and polynucleotides encoding same |
| 04/25/2002 | WO2001014846A3 Methods and assay kits for detecting a pro-ms immune response via assay of B cells |
| 04/25/2002 | US20020049988 Transgenic animals harboring APP allele having swedish mutation |
| 04/25/2002 | US20020049159 Methods and compositions for the treatment of motor neuron injury and neuropathy |
| 04/25/2002 | US20020049151 Therapeutic approaches to diseases by suppression of the NURR subfamily of nuclear transcription factors |
| 04/25/2002 | US20020048801 Peptide with enzymatic activity; for use as diagnostic tools in detecting cancer and cardiovascular and liver disorders |
| 04/25/2002 | US20020048786 Nucleotide sequences for use in the treatment of infections, arthritis, karposi's sarcoma, allergies, asthma, nervous system and autoimmune diseases |
| 04/25/2002 | US20020048785 Novel polypeptides within the tumor necrosis factor receptor superfamily and uses therefor |
| 04/25/2002 | US20020048784 Prostatic growth factor |
| 04/25/2002 | US20020048783 Immunoglobulin for use in the detection of preferential proteins in bodily fuids of mammals |
| 04/25/2002 | US20020048777 Nucleotide sequences for use in therapy, monitoring and screning preferential tumors |
| 04/25/2002 | US20020048769 Protein-protein interactions in neurodegenerative disorders |
| 04/25/2002 | US20020048586 Therapeutic compositions that alter the immune response |
| 04/25/2002 | US20020048585 Decreasing syndecan-4 expression, level, or activity |
| 04/25/2002 | US20020048583 Combining ex vivo an antigen and an antigen-presenting cell binding agent specific for the antigen, and administering the composition to a patient suffering from a disease associated with the antigen |
| 04/25/2002 | US20020048579 Treated tissue or organ can be transplanted in a recipient with reduced risk of graft-versus-host disease. |
| 04/25/2002 | US20020048578 Modified version of a therapeutic antibody with affinity for a cell-surface antigen; capable of inducing immunological tolerance to the therapeutic antibody |
| 04/25/2002 | US20020048562 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
| 04/25/2002 | CA2818654A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464121A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2453140A1 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
| 04/25/2002 | CA2426424A1 Haemophilus influenzae basb206 gene and protein |
| 04/25/2002 | CA2426413A1 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae |
| 04/25/2002 | CA2426371A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425763A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | CA2425723A1 Neuromedin u delta |
| 04/25/2002 | CA2425669A1 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | CA2425662A1 Osteopontin-coated surfaces and methods of use |
| 04/25/2002 | CA2425362A1 Basb208 nucleotide and amino acid sequences from haemophilus influenzae |
| 04/25/2002 | CA2425174A1 Human gene critical to fertility |
| 04/25/2002 | CA2424643A1 Cd38 modulated chemotaxis |
| 04/25/2002 | CA2424371A1 Agonistic monoclonal antibody fragments |
| 04/25/2002 | CA2423843A1 Uses of monoclonal antibody 8h9 |
| 04/25/2002 | CA2423073A1 Recombinant antibody fragments as autoantibody antagonists |
| 04/25/2002 | CA2418835A1 Protein scaffolds for antibody mimics and other binding proteins |
| 04/25/2002 | CA2405906A1 Remedies or preventives for rheumatoid arthritis |
| 04/25/2002 | CA2394670A1 Immunoenzymatic quantification method |
| 04/24/2002 | EP1199372A2 Polymorphisms in the human P2X7 gene |
| 04/24/2002 | EP1199363A1 Phosphorylation modifications of apoptin |
| 04/24/2002 | EP1199362A2 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR) |
| 04/24/2002 | EP1199361A2 Glycoprotein hormone receptor molecules. Their uses |
| 04/24/2002 | EP1199360A2 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor |
| 04/24/2002 | EP1199359A1 Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and related DNA compounds |
| 04/24/2002 | EP1199081A1 Use of inhibition of a growth arrest-specific gene (gas6) function or of a gas6 receptor for preventing and treating a thromboembolic disease |
| 04/24/2002 | EP1198711A1 Method for diagnosing cancerous diseases and/or neuro-degenerative pathological conditions and products therefor |
| 04/24/2002 | EP1198571A2 Chimeric proteins |
| 04/24/2002 | EP1198569A1 G-protein coupled receptor and dna sequences thereof |
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198563A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 04/24/2002 | EP1198560A2 Mammalian adhesion protease peptides |
| 04/24/2002 | EP1198480A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 04/24/2002 | EP1198479A1 Neovascular-targeted immunoconjugates |
| 04/24/2002 | EP1198475A1 Highly purified cytokine activating factor and methods of use |
| 04/24/2002 | EP1198468A1 Stabilized viral envelope proteins and uses thereof |
| 04/24/2002 | EP1198251A1 Combination of an anti-ep-cam antibody with a chemotherapeutic agent |
| 04/24/2002 | EP1198238A2 Gene encoding nade, p75ntr -associated cell death executor and uses thereof |
| 04/24/2002 | EP0752008B1 Dna mutagenesis by random fragmentation and reassembly |
| 04/24/2002 | EP0649536B1 Assay for chagas' disease and reagents for its use |
| 04/24/2002 | CN1346406A Human ubiquitin ligase E3 for the modulation of NF-kappa 8 |
| 04/24/2002 | CN1346372A Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 04/24/2002 | CN1346371A Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 04/24/2002 | CN1346370A Polypeptides involved in immune response |
| 04/24/2002 | CN1346368A Potassium channel interactors and uses therefor |
| 04/24/2002 | CN1346284A CD 40 binding molecules and CTL peptides for treating tumors |
| 04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
| 04/24/2002 | CN1346280A Immunoadsorber for use in sepsis therapy |
| 04/24/2002 | CN1346279A Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 04/24/2002 | CN1345979A Novel polypeptide-DNA topoisomerase II 12.76 and polynucleotide for encoding said polypeptide |